Clinical Trial Update: Anti-CD19 White Blood Cells for Children and Young Adults With B Cell Leukemia or Lymphoma [Phase 1]

View source ↗

Summary

Phase 1 trial of anti-CD19 white blood cells in children and young adults with B-cell leukemia or lymphoma completed; results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• B-cell Lymphoma
• Non-hodgkin Lymphoma

Drugs mentioned

• anti-CD19 white blood cells (anti-CD19 white blood cells)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: ALL, B Cell Lymphoma | Phase 1 | Status: COMPLETED | Results posted: 2020-08-31